FindTrial
Sign In

Vitamin D sufficiency and glcemic control in children with type 1 diabetes mellitus

Vitamin D Supplementation and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus: a double blind randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013812
Enrollment
50
Registered
2018-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 1 diabetes mellitus Health Condition 2: E109- Type 1 diabetes mellitus without complications

Interventions

Intervention1: Vitamin D: Calcirol satchets 60,000 IU every month for 3 months Control Intervention1: Placebo: Similar packaged 1 satchet every month for 3 months

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with type 1 diabetes mellitus for minimum duartion 1 year

Exclusion criteria

Exclusion criteria: Liver or kidney disease Coeliac disease Use of medications affecting vitamin D Métabolism HbA1c > 10 or < 6.5

Design outcomes

Primary

MeasureTime frame
Glycemic control in the form of HbA1cTimepoint: Glycemic control in the form of HbA1c at the end of 3 months of starting intervention—

Secondary

MeasureTime frame
Serum vitamin D levels at the end if therapyTimepoint: 3 months after 1 dose of vitamin D—

Countries

India

Contacts

Public ContactDevi Saranya S

AIIMS NEW DELHI

drrajnisharma@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026